REG - Science Group PLC - Transaction in Own Shares

ScienceAnnouncement

18/05/2020 07:01

RNS Number : 1131N
  
Science Group PLC
  
18 May 2020
  
 

 
 
 18 May 2020
 
Science Group plc
(the "Company" or "Science Group")
 
Transaction in own shares
 
Science Group plc (AIM:SAG) announces that, on 15 May 2020, it purchased 10,000 of its 1 pence ordinary shares at an average price of 204.7 pence per share. The highest price paid per share was 204.7 pence and the lowest price paid per share was 204.7 pence. The Company purchased these shares through Liberum Capital Limited.
The number of shares purchased represented 0.02% of the voting rights attributable to the total ordinary shares in issue prior to the purchase. The purchased shares will be held in treasury.
The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 41,668,579.  Science Group holds 393,456 shares in treasury.  The total number of voting rights in the Company following this announcement is 41,564,179.
The figure of 41,564,179 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure and Transparency Rules.
 
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Liberum Capital Limited on behalf of the Company as part of the buyback programme.
 



Number of shares purchased


Transaction price (per share)


Time of transaction


Execution venue




10000


204.7


16:11:37


AIMX



 
- Ends -
 
 




 
For further information:
 



Science Group plc








Sarah Cole, Company Secretary


Tel: +44 (0) 1223 875 200



 



Panmure Gordon (UK) Limited








Nominated Adviser: Dominic Morley/Alina Vaskina


Tel: +44 (0) 20 7886 2500




Corporate Broking: Erik Anderson







 



Liberum Capital Limited


Tel: +44 (0) 20 3100 2000




Neil Patel/Cameron Duncan/Robert Morton/Ed Phillips







 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
POSKKPBPPBKDQPD